ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 33 filers reported holding ACORDA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,160,000 | -50.4% | 5,100,000 | -46.9% | 0.16% | -64.4% |
| Q2 2016 | $8,388,000 | -2.2% | 9,600,000 | 0.0% | 0.44% | +2.1% |
| Q1 2016 | $8,580,000 | -22.8% | 9,600,000 | 0.0% | 0.43% | -29.8% |
| Q4 2015 | $11,112,000 | +28.3% | 9,600,000 | 0.0% | 0.61% | +71.1% |
| Q3 2015 | $8,664,000 | – | 9,600,000 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 8,750,000 | $6,650,000 | 3.76% |
| Mohican Financial Management, LLC | 3,000,000 | $2,280,000 | 2.84% |
| BASSO CAPITAL MANAGEMENT, L.P. | 11,200,000 | $8,512,000 | 1.28% |
| ANGELO GORDON & CO., L.P. | 22,500,000 | $17,100,000 | 1.26% |
| Context Capital Management, LLC | 1,500,000 | $1,140,000 | 1.25% |
| Opera Trading Capital | 4,500,000 | $3,400,000 | 1.02% |
| Jabre Capital Partners S.A. | 6,650,000 | $5,037,000 | 0.58% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $4,576,000 | 0.44% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 28,000,000 | $21,345,000,000 | 0.41% |
| Man Investments (CH) AG | 700,000 | $536,000 | 0.31% |